Try our Advanced Search for more refined results
February 13, 2019
In Re: Ranbaxy Generic Drug Application Antitrust Litigation
Case Number:
1:19-md-02878
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Multi Party Litigation:
Multi-district Litigation, Class Action
Judge:
Firms
- ArentFox Schiff
- Berman Tabacco
- Cohen Milstein
- Covington & Burling
- Dugan Law Firm
- Hagens Berman
- Haynes & Boone
- Hilliard & Shadowen
- Kessler Topaz
- Kirkland & Ellis
- Lowey Dannenberg
- Marshall Halem
- McCarter & English
- McEldrew Purtell
- Mintz Levin
- Nussbaum Law Group
- Parker Poe
- Pendley Baudin
- Radice Law Firm
- Sperling & Slater
- Sugarman Rogers
- Wexler Boley
- White & Case
Companies
- AstraZeneca PLC
- LifeWallet
- Prinston Pharmaceutical Inc.
- Ranbaxy
- Sun Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 20, 2022
'Excessive' Atty Fee Bid In Ranbaxy MDL Slashed By $36M
A Boston federal judge has cut $36 million from an "excessive" fee request by attorneys for two classes of plaintiffs who settled multidistrict antitrust claims against Ranbaxy Pharmaceuticals for $485 million.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login